Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 916465
                    [Title] => US panel sees risk in long-used osteoporosis drug
                    [Summary] => 
A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

                    [DatePublished] => 2013-03-06 10:40:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

NOVARTIS AND UPSHER-SMITH

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 916465
                    [Title] => US panel sees risk in long-used osteoporosis drug
                    [Summary] => 
A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

                    [DatePublished] => 2013-03-06 10:40:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

US panel sees risk in long-used osteoporosis drug

March 6, 2013 - 10:40am

A panel of U.S. government health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of can...

Health And Family